Stereotaxis assesses biologic agent-delivery
This article was originally published in Clinica
Executive Summary
Eyeing the market for delivering therapeutic biologic agents, Stereotaxis is assessing use of its magnetic navigation platform with a magnetically-enabled endocardial injection catheter developed in collaboration with Biologics Delivery Systems, a unit of Johnson & Johnson subsidiary Cordis.